The reported efficacy rates of 94 or 95 percent are for symptomatic disease only. Because the clinical trials for Pfizer and Moderna did not require regular testing for COVID-19, they were not a good indication of how well the vaccine protects against asymptomatic disease (which account for some 40 percent of cases).
原話見內
本文內容已被 [ dudaan ] 在 2021-02-01 06:19:50 編輯過。如有問題,請報告版主或論壇管理刪除.